Advisory Board and Editors Translational Medicine
David Kennedy
Our lab studies how interrelated organ systems such as heart, kidney and liver regulate cellular damage (particularly inflammation and fibrosis) and repair during the course of chronic ailments such as heart failure, hypertension, diabetes, obesity and chronic kidney disease. We are particularly interested in developing new preventative and therapeutic strategies to help people suffering from these diseases through establishing novel biomarkers and molecular diagnostics to assist risk stratification as well as identifying new drugs and drug targets and enhancing endogenous counter-regulatory mechanisms. Given our community’s ties to and dependence on the Great Lakes as a source of clean water for drinking, recreation, fishing and agriculture, our laboratory also places a special emphasis on discovering new diagnostic, preventative and therapeutic strategies targeting cellular damage caused by environmental stressors that impair our land-water-food nexus.
William A. Knaus
Director of Applied Genomics in Informatics at Center for Clinical Research in Informatics, NorthShore Research Institute Evanston, Illinois and Professor of Medicine University of Chicago. Former Evelyn Troup Hobson Professor & Founding Chair Department of Public Health Sciences, M.D., University of Virginia School of Medicine (1995-2012). Director ICU Research George Washington University School of Medicine & founder, former board member and CEO of Apache Medical Systems (Inc.) 1988-2000.
Mei-Chuan Ko
Professor in the Department of Psychiatry, University of Pittsburgh School of Medicine. My research interests involve behavioral neuropharmacology of pain and addiction, including 1) biological basis and pharmacotherapy for drug abuse and dependence and 2) neuropharmacological basis of therapeutics of analgesics and antipruritics.
Prasanna Krishnamurthy
Dr. Prasanna earned his BVSc (DVM) degree with honors from Bangalore Veterinary College and completed his Masters and PhD in Veterinary Pathology from Indian Veterinary Research Institute (India's premier institute for Veterinary Research). He completed his postdoctoral training at Northwestern University (in Dr. Raj Kishore's laboratory) and East Tennessee State University. Before joining University of Alabama at Birmingham (UAB), he held faculty appointments at the Feinberg Cardiovascular Research Institute, Northwestern University School of Medicine, Chicago, Illinois and Houston Methodist Research Institute, Texas.
As a member of the Department of Biomedical Engineering, he directs a research program focusing on understanding mechanisms of cardiovascular diseases and developing novel therapeutic strategies to promote cardiac regeneration and repair. Dr. Krishnamurthy’s laboratory is supported through funds from National Institutes of Health (NIH-R01) and American Heart Association (GIA and Postdoctoral fellowships).
Hang Fai Kwok
Prof Kwok’s research interests mainly focus on the development of novel monoclonal antibodies and venom-based peptides as prototype drugs for anticancer and anti-inflammatory therapies. In addition, Prof. Kwok’s research group is also expanding scientific knowledge and research in the areas of existing and novel cancer biomarkers such as 1) matricellular protein — OPN, 2) metalloproteinase — ADAM17 & ADAMTS5, 3) DNA replication licensing factor — MCM proteins, 4) small GTP binding protein — RAN, as well as immunotherapy markers (e.g. PD-1/PD-L1) in order to identify and validate their prognostic and therapeutic values according to the roles in hallmarks of cancer.
Julia Kzhyshkowska
1997: PhD Cancer Research Centre of the Russian Academy of Medical Sciences, Moscow.
1997-2001: Postdoc at the University of Regensburg
2001-2007: Junior group leader/PI and lecturer, University of Heidelberg.
2007- 2010:Senior group leader/PI and senior lecturer, University of Heidelberg
2010-2013: Professor, head of the Lab for Cellular and Molecular Biology of Innate Immunity;
2013-permanent: Professor, head of Department for Innate Immunity and Tolerance, University of Heidelberg.
B Duncan X Lascelles
After graduating from the veterinary program at the University of Bristol, U.K., with honors, Dr. Lascelles completed a PhD in aspects of pre-emptive/perioperative analgesia at the University of Bristol. After an internship there, he completed his surgical residency at the University of Cambridge, U.K. and then a Fellowship in Oncological Surgery at Colorado State University. He is currently Professor in Small Animal Surgery and Pain Management at North Carolina State University.
Ning Li
Prof. Li received his Medical Doctorate in 2005 as an outstanding graduate of the Chinese Union Medical University (CUMU). In the same year, he worked in the Department of Thoracic Surgery at the Cancer Hospital of the Chinese Academy of Medical Sciences, where he served as an attending physician, deputy chief physician, and was appointed Chief Physician in 2019. He has a solid theoretical foundation and excellent research ability, and has accumulated rich clinical experience during my work. In 2017, he took over as the Director of the Office of Drug Clinical Trial Research Center, and his outstanding achievements in the management of clinical trial institutions and clinical and translational research, and is currently served as the chief expert of China GCP platform and Leading PI of international multicenter clinical trials of anti-cancer drug discovery. He is committed to new anti-tumor drug research, real-world research, full chain translation research of clinical trials, precision treatment of rare tumors and tumor big data research. His H-Index is 44 based on Web of Science. As a sub-project leader of the National 973 Major Project, the National Key R&D Program for Precision Medicine, the National Natural Science Foundation of China, the GCP platform leader, and the leader of the 13th and 14th Five-Year Innovation Project, he has undertaken many research projects.
Dongliang Liu
Dr. Dongliang Liu is a Postdoctoral Associate in the Department of Surgery at the Baylor College of Medicine. His research interests include: Cancer therapy, especially for pancreatic cancer immunotherapy; Chimeric virus-like particles (VLP) vaccine, especially for cancer vaccines; Novel antibiotics development including antimicrobial peptides; Epitomics and multi-epitope peptide vaccine development for pathogenic viruses.
Laurent Metzinger
Laurent Metzinger has completed his PhD in Biological Sciences and Pharmaceutical studies in Strasbourg, France and was a postdoctoral fellow from the University of Oxford (UK) in a leading lab on Duchenne muscular Dystrophy (Pr. Kay Davies). He works on microRNA regulation in the HEMATIM team in Amiens, and focuses on anemia and related vascular disorders associated with Chronic Kidney DIsease. He has authored some of the first papers showing a role for microRNAs in CKD and published in reputed journals, including Nature and Cell. He teaches Biochemistry, Genetics and Molecular Biology in the Pharmacy School of Amiens (Université de Picardie Jules Verne).
Carla Minoia
Dr. Carla Minoia is a MD at IRCCS Istituto Tumori "Giovanni Paolo II" Bari (Italy). Her PhD involved clinical research on lymphoma, survivorship, and quality of life.
Thimios A Mitsiadis
Professor of Oral Biology in the Medical Faculty at the University of Zurich, Switzerland since 2006. Research in the fields of stem cells, genetics, molecular and experimental biology related to orofacial developmental and regeneration processes.
DDS degree from the Dental Faculty of the Kapodistrion University of Athens (Greece), Master degree for Immunology, Genetics and Differentiation, and PhD in Developmental Biology from the University of Lyon (France). Postdoctoral studies at the University of Helsinki (Finland), Karolinksa Nobel Institute (Stockholm, Sweden) and Yale University (USA). Previously Professor at the Mediterranean University (Marseilles, France), Visiting Professor at the Ecole Normale Superieure of Lyon (France), Clinical Senior Lecturer at King's College London (UK), Visiting Professor at the Polytechnic University of Marche (Ancona, Italy), Visiting Professor at the Second University of Napoli (Napoli, Italy). Chief-Editor of the “Frontiers of Craniofacial Biology and Dental Research”, Associate Editor of “Stem Cell Research”, Scientific Editor of “European Cells & Materials”, and part of the editorial board in additional 8 scientific journals. More than 110 original articles in journals such as “Journal of Cell Biology”, “Development”, “Developmental Biology”, “Nature Genetics”, “Science Signaling”, “Scientific Reports”, “Frontiers in Physiology” and more than 200 keynote and invited lectures.